Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Companion Diagnostics » Burning Rock Bio, CStone Pharmaceuticals to Codevelop CDx for Pralsetinib in China

Burning Rock Bio, CStone Pharmaceuticals to Codevelop CDx for Pralsetinib in China

Jun 29, 2020
|
staff reporter

NEW YORK – Chinese molecular diagnostics firm Burning Rock Biotech announced Sunday a strategic collaboration with CStone Pharmaceuticals to co-develop and commercialize companion diagnostics for Blueprint Medicines' pralsetinib in China.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Millions of Tests

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Court Pick and Science

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Arthur Ashkin Dies

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

PNAS Papers on Alzheimer's Transcriptomes, Bladder Cancer Mutations, CRC Drivers

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.

Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

What's Popular?

In Companion Diagnostics

  1. Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.